Surgical site infections in patients undergoing breast oncological surgery during the lockdown: An unexpected lesson from the COVID-19 pandemic.

IF 0.4 Q4 SURGERY

Giornale di Chirurgia Pub Date : 2022-07-25 eCollection Date: 2022-08-01 DOI:10.1097/IA9.0000000000000003

Sonia Cappelli, Diletta Corallino, Marco Clementi, Stefano Guadagni, Fabio Pelle, Ilaria Puccica, Maddalena Barba, Patrizia Vici, Isabella Sperduti, Maurizio Costantini, Claudio Botti

{"title":"Surgical site infections in patients undergoing breast oncological surgery during the lockdown: An unexpected lesson from the COVID-19 pandemic.","authors":"Sonia Cappelli, Diletta Corallino, Marco Clementi, Stefano Guadagni, Fabio Pelle, Ilaria Puccica, Maddalena Barba, Patrizia Vici, Isabella Sperduti, Maurizio Costantini, Claudio Botti","doi":"10.1097/IA9.0000000000000003","DOIUrl":null,"url":null,"abstract":"Background: The present study aims to evaluate how the measures to contain the SARS-CoV-2 spreading affected the surgical site infections (SSIs) rate in patients who underwent nondeferrable breast cancer surgery (BCS).Methods: This study is a retrospective analysis of prospectively collected data from a consecutive series of patients underwent nondeferrable BCS in a regional Italian Covid-free hub during two different period: March to April 2020 (pandemic cohort [PC]) and March till April 2019 (control cohort [CC]). SSIs were defined according to the criteria established by the Center for disease control and prevention (CDC) and additional treatment, serous discharge, erythema, purulent exudate, separation of deep tissues, isolation of bacteria, and stay (ASEPSIS) scoring systems.Results: One hundred ninety-nine patients were included in the present study: 100 and 99 patients who underwent nondeferrable BCS from March to April 2020 (PC) and from March to April 2019 (CC), respectively. The overall SSIs rate in this series was 9.1% according to CDC criteria and 6.5% according to ASEPSIS criteria. The SSIs incidence decreased during the pandemic period. Moreover, the SSIs rate according to ASEPSIS criteria was statistically lower in the PC than in the CC. We observed significant evidence of higher SSIs, both in terms of CDC and ASEPSIS score, in patients having undergone breast reconstruction compared with patients not undergoing immediate reconstruction.Conclusions: The restrictive measures issued during the lockdown period seemed to lower the SSIs rates in patients undergoing nondeferrable BCS.","PeriodicalId":46352,"journal":{"name":"Giornale di Chirurgia","volume":"42 2","pages":"e02"},"PeriodicalIF":0.4000,"publicationDate":"2022-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3a/10/ia9-42-e02.PMC9323553.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Giornale di Chirurgia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/IA9.0000000000000003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/8/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The present study aims to evaluate how the measures to contain the SARS-CoV-2 spreading affected the surgical site infections (SSIs) rate in patients who underwent nondeferrable breast cancer surgery (BCS).

Methods: This study is a retrospective analysis of prospectively collected data from a consecutive series of patients underwent nondeferrable BCS in a regional Italian Covid-free hub during two different period: March to April 2020 (pandemic cohort [PC]) and March till April 2019 (control cohort [CC]). SSIs were defined according to the criteria established by the Center for disease control and prevention (CDC) and additional treatment, serous discharge, erythema, purulent exudate, separation of deep tissues, isolation of bacteria, and stay (ASEPSIS) scoring systems.

Results: One hundred ninety-nine patients were included in the present study: 100 and 99 patients who underwent nondeferrable BCS from March to April 2020 (PC) and from March to April 2019 (CC), respectively. The overall SSIs rate in this series was 9.1% according to CDC criteria and 6.5% according to ASEPSIS criteria. The SSIs incidence decreased during the pandemic period. Moreover, the SSIs rate according to ASEPSIS criteria was statistically lower in the PC than in the CC. We observed significant evidence of higher SSIs, both in terms of CDC and ASEPSIS score, in patients having undergone breast reconstruction compared with patients not undergoing immediate reconstruction.

Conclusions: The restrictive measures issued during the lockdown period seemed to lower the SSIs rates in patients undergoing nondeferrable BCS.

Abstract Image

查看原文本刊更多论文

封锁期间乳腺肿瘤手术患者的手术部位感染：从 COVID-19 大流行中汲取的意外教训。

背景：本研究旨在评估遏制SARS-CoV-2传播的措施如何影响接受不可抗乳腺癌手术（BCS）患者的手术部位感染（SSI）率：本研究是对前瞻性收集的数据进行的回顾性分析，这些数据来自两个不同时期在意大利地区无Covid中心接受非传染性乳腺癌手术的连续系列患者：2020年3月至4月（大流行队列 [PC]）和2019年3月至4月（对照队列 [CC]）。SSI 的定义依据疾病控制和预防中心（CDC）制定的标准以及附加治疗、血清分泌物、红斑、脓性渗出物、深部组织分离、细菌分离和停留（ASEPSIS）评分系统：本研究共纳入了 199 名患者：结果：本研究共纳入 199 名患者：分别有 100 名和 99 名患者在 2020 年 3 月至 4 月（PC）和 2019 年 3 月至 4 月（CC）期间接受了非手术 BCS。根据美国疾病预防控制中心（CDC）的标准，该系列患者的 SSIs 总发生率为 9.1%，根据 ASEPSIS 标准，该系列患者的 SSIs 总发生率为 6.5%。在大流行期间，SSIs 发生率有所下降。此外，根据 ASEPSIS 标准，PC 的 SSIs 发生率在统计学上低于 CC。我们观察到，与未立即进行乳房再造的患者相比，接受过乳房再造的患者在 CDC 和 ASEPSIS 评分方面均有明显证据表明 SSI 较高：结论：在封锁期间采取的限制性措施似乎降低了接受非硬膜外BCS手术的患者的SSI感染率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Giornale di Chirurgia SURGERY-

CiteScore

1.10

自引率

0.00%

发文量

期刊介绍： Il Giornale di Chirurgia pubblica contributi che propongono le diverse tecniche su patologia chirurgiche di attualità. Pubblica articoli originali, casistica clinica, metodi, tecniche, terapia farmacologica pre-operatoria e post-chirurgica, ed articoli inerenti la descrizione di tecniche chirurgiche.